Functional characterization of human Tc0, tc1 and Tc2 cd8+ T cell clones: Control of X4 and R5 HIV strain replication

Journal of Clinical Immunology

Volumn 24, Issue 3, 2004, Pages 272-280

  Février, Michèle ^a   Borgne, Sylvie L E ^a,d   Marty, Christian ^b   Talarmin, Antoine ^c,e   Rivière, Yves ^a  

^a INSTITUT PASTEUR   (France)

^b Serv de la Lutte Anti venerienne   (French Guiana)

^c CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^d IDM   (France)

^e INSTITUT PASTEUR DE BANGUI   (Central African Republic)

Author keywords

CAF; CD8+ T cell clones; HIV; Phenotype; Viral replication

Indexed keywords

CD8 T LYMPHOCYTE ANTIVIRUS FACTOR; T LYMPHOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL CLONING; CELL FUNCTION; CONTROLLED STUDY; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION; VIRUS REPLICATION;

CLONE CELLS; CYTOKINES; FEMALE; HIV-1; HUMANS; MALE; RNA-DIRECTED DNA POLYMERASE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; VIRUS REPLICATION;

EID: 3543050093     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOCI.0000025448.08570.2d     Document Type: Article

References (48)

1. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145-173, 1989
2. Romagnani S: Lymphokine production by human T cells in disease states. Ann Rev Immunol 12:227-257, 1994
3. Kamogawa Y, Minasi LA, Carding SR, Bottomly K, Flavell RA: The relationship of IL4 and IFNγ producing cells studied by lineage ablation of IL4 producing cells. Cell 75:985-995, 1993
4. Kelso A, Troutt AB, Maraskovsky E, Gough NM, Morris L, Pech MH, Thomson JA: Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro. Immunol Rev 123:85-114, 1991
5. Noble A, Macary PA, Kemeny DM: IFNγ and IL4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles. J Immunol 155:2928-2937, 1995
6. Maggi E, Giudizi MG, Biagiotti R, Annunziato F, Manetti R, Piccini M-P, Parronchi P, Sampognaro S, Giannarini L, Zuccati G, Romagnani S: Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 180:489-495, 1994
7. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR: Differing lymphokine profiles of functional subsets of human CD4 and CD8 cell clones. Science 254:279-282, 1991
8. Sad S, Marcotte R, Mosmann TR: Cytokine-induced differenciation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2:271-279, 1995
9. Croft M, Carter L, Swain SL, Dutton RW: Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)4 and IL12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180:1715-1728, 1994
10. Maggi E, Manetti R, Annunziato F, Cosmi L, Giudizi MG, Biagiotti R, Galli G, Zuccati G, Romagnani S: Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus-infected individuals. Blood 89:3672-3681, 1997
11. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Ann Rev Immunol 12:635-673, 1994
12. Halverson DC, Schwartz GN, Carter C, Gress RE, Fowler DH: In vitro generation of allospecific human CD8+ T cells of Tc1 and Tc2 phenotype. Blood 90:2089-2096, 1997
13. Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM: Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 95:231-240, 2000
14. Conlon K, Lloyd A, Chattopadhyay U, Lukacs N, Kunkel S, Schall T, Taub D, Morimoto C, Osborne J, Oppenheim J: CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 alpha, interleukin-8 and RANTES. Eur J Immunol 25:751-756, 1995
15. Cocchi F, De Vico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P: Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815, 1995
16. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666, 1996
17. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashina KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673, 1996
18. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor (see comments). Science 272:872-877, 1996
19. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958, 1996
20. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835, 1996
21. Walker CM, Moody DJ, Stites DP, Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566, 1986
22. Baier M, Werner A, Bannert N, Metzner K, Kurth R: HIV suppression by interleukin-16. Nature 378:563, 1995
23. Yang OO, Walker BD: CD8+ cells in human immunodeficiency virus type 1 pathogenesis: Cytolytic and noncytolytic inhibition of viral replication. Adv Immunol 66:273-311, 1997
24. Mackewicz CE, Ortega H, Levy JA: Effect of cytokines on HIV replication in CD4+ lymphocytes: Lack of identity with the CD8+ cell antiviral factor. Cell Immunol 153:329-343, 1994
25. Moriuchi H, Moriuchi M, Combadiere C, Murphy PM: CD8+ T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci USA 93:15341-15345, 1996
26. Lacey SF, McDanal CB, Horuk R, Greenberg ML: The CXC chemokine stromal cell-derived factor-1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1. Proc Natl Acad Sci USA 94:9842-9847, 1997
27. Chen CH, Weinhold KJ, Bartlett JA, Bolognesi DP, Greenberg M: CD8+ T lymphocyte mediated inhibition of HIV-long terminal repeat transcription: A novel antiviral mechanism. AIDS Res Hum Retroviruses 9:1079-1086, 1993
28. Mackewicz CE, Blackbourne DJ, Levy JA: CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 92:2308-2312, 1995
29. Chang TL, Mosoian A, Pine R, Klotman ME, Moore JP: A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol 76:569-581, 2002
30. Copeland KF, McKay PJ, Rosenthal KL: Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Res Hum Retroviruses 11:1321-1326, 1995
31. Le Borgne S, Février M, Callebaut C, Lee SP, Rivière Y: CD8+ cell antiviral factor (CAP) activity is not restricted to HIV specific T cells and can block HIV replication after the initiation of reverse transcription. J Virol 74:44-56, 2000
32. Cao Y, Qin L, Zhang L, Safrit J, Ho DD: Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332:201-208, 1995
33. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat Med 2:412-417, 1996
34. Stransford SA, Skurnick J, Louria D, Osmond D, Chang S-Y, Sninsky J, Ferrari G, Weinhold KJ, Lindquist C, Levy JA: Lack of infection in HIV-exposed individuals is associated with a strong CD8+ cell noncytolitic anti-HIV response. Proc Natl Acad Sci USA 96:1030-1035, 1999
35. Moretta A, Pantaleo G, Cerottini JC, Mingari MC: Direct demonstration of the clonogenic potential of every human peripheral blood T cell: Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med 157:743-754, 1983
36. Li Y, Hui H, Burgess CJ, Price RW, Sharp PM, Hahn BH, Shaw GM: Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: Evidence for limited defectiveness and complementation. J Virol 66:6587-6600, 1992
37. Prussin C: Cytokine flow cytometry: Understanding cytokine biology at the single cell level. J Clin Immunol 17:195-204, 1997
38. Conlon K, Osborne J, Morimoto C, Ortaldo JR, Young HA: Comparison of lymphokine secretion and RNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes. Eur J Immunol 25:644-648, 1995
39. Schrum S, Probst P, Fleischer B, Zipfer PF: Synthesis of the CC-chemokines MIP-1α, MIP-1β and RANTES is associated with type 1 immune response. J Immunol 157:3598-3604, 1996
40. Butera ST, Pisell TL, Limpakarnjanarat K, Young NL, Hodge TW, Mastro TD, Folks TM: Production of a novel viral suppressive activity associated with resistance to infection among femal sex workers exposed to HIV-type 1. AIDS Res Hum Retroviruses 17:735-744, 2001
41. Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, Kimani J, Krausa P, Bwayo J, Simonsen JN, Shearer GM, Plummer FA: HIV type 1 resistance in kenyan sex workers is associated with altered cellular susceptibility of HIV type 1 infection or enhanced β-chemokine production. AIDS Res Hum Retroviruses 14:1521-1530, 1998
42. Meyaard L, Fouchier RA, Brouwer M, Hovenkamp E, Miedema F: Syncytium-inducing HIV-1 variants replicate equally well in all types of T-helper cell clones. AIDS 10:1598-1600, 1996
43. Mikovits JA, Taub DD, Turcovski-Corrales SM, Ruscetti FW: Similar level of human immunodeficiency virus type-1 replication in human Th1 and Th2 clones. J Virol 72:5231-5238, 1998
44. Mackewicz CE, Barker E, Greco G, Reyes-Teran G, Levy JA: Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest 100:921-930, 1997
45. Rubbert A, Weissman D, Combadiere C, Pettrone KA, Daucher JA, Murphy PM, Fauci AS: Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: Beta-chemokine-dependent and -independent effects. AIDS Res Hum Retroviruses 13:63-69, 1997
46. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, Ho DD: Contribution of human α-defensin-1, -2, and -3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298:995-1000, 2002
47. Chang TL, Francois F, Mosoian A, Klotman ME: CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol 77:6777-6784, 2003
48. Greco G, Barker E, Levy JA, Mackewicz CE, Reyes-Teran G: Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production. AIDS Res Hum Retroviruses 14:1407-1411, 1998